RIGEL PHARMACEUTICALS INC — Director's Dealing 2011

Feb 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2011-02-01

Reporting Person: PAYAN DONALD G (Director, EVP, Pres. Discovery&Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-01	Stock Option (Right to Buy)	$6.73	A	65000	Acquired	2021-02-01	Common Stock (65000)	Direct

Footnotes

F1: Vests monthly over one (1) year from January 1, 2011.